<qa>  What is the phase II study to evaluate the efficacy and safety of docetaxelThis is an open-label, phase II study to evaluate the efficacy and safety of biweekly docetaxel, Oxaliplatin and de Gramont regimen on unresectable gastric adenocarcinoma in the first-line therapy. 